Allianz Asset Management
RLAY icon

Allianz Asset Management’s Relay Therapeutics RLAY Stock Holding History

Allianz Asset Management’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$750K Buy
+40,100
New +$582K ﹤0.01% 1939
2026
Q1 		– Sell
-560,298
Closed -$4.74M – 2093
2025
Q4 		$4.74M Buy
+560,298
New +$4M ﹤0.01% 1162
2023
Q2 		– Sell
-16,100
Closed -$265K – 2264
2023
Q1 		$265K Hold
16,100
– – ﹤0.01% 2006
2022
Q4 		$241K Hold
16,100
– – ﹤0.01% 1846
2022
Q3 		$360K Buy
+16,100
New +$353K ﹤0.01% 1576
2021
Q2 		– Sell
-6,310
Closed -$218K – 2466
2021
Q1 		$218K Sell
6,310
-4,495
-42% -$195K ﹤0.01% 2110
2020
Q4 		$449K Buy
+10,805
New +$488K ﹤0.01% 1655

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

Allianz Asset Management's RLAY Position: Q2 2026 in Review

Allianz Asset Management opened a new position in Relay Therapeutics (RLAY) in Q2 2026: 40,100 shares worth $750K. The stake represents ﹤0.01% of the portfolio and ranks #1939 among its holdings. This is a return to the name: Allianz Asset Management previously reported a position in RLAY as recently as Q4 2025.

Allianz Asset Management first reported a position in RLAY in Q4 2020 and has held it in 7 quarters since. The position peaked at $4.74M in Q4 2025. 260 funds tracked by Wall St. Rank hold RLAY as of Q2 2026.

  • Allianz Asset Management held 40,100 shares of Relay Therapeutics worth $750K as of Q2 2026.
  • Relay Therapeutics was a new Allianz Asset Management position in Q2 2026.
  • Relay Therapeutics made up ﹤0.01% of Allianz Asset Management's portfolio in Q2 2026, its #1939 holding.
  • Allianz Asset Management first reported a position in Relay Therapeutics in Q4 2020 and has held it in 7 quarters since.
  • Allianz Asset Management's Relay Therapeutics position peaked at $4.74M in Q4 2025.
  • 260 funds tracked by Wall St. Rank held Relay Therapeutics as of Q2 2026.

Based on Allianz Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.